SAN DIEGO, CA, October 21, 2021 (GLOBE NEWSWIRE) - Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a biopharmaceutical...
Celltrion has declared that it has completed the process of requesting approval of CT-P16, a biosimilar of Avastin (ingredient: bevacizumab),...
HANOVER, Germany, October 7, 2021 / CNW / - india The Central Drugs Standard Control Organization (CDSCO) has granted Syntellix...
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
Celltrion said it submitted a Marketing Authorization (MAA) application for Regkirona, a treatment for Covid-19, to the European Medicines Agency...
RESEARCH TRIANGLE PARK - Cambrex Corp., a contract manufacturer of small molecule therapies with major facilities in High Point and...
